GlassScriptPhysician profile
David M Albala
NPI 1386734531
$138,730.15
in general payments reported to CMS, 2019-2025
56 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $26K · 2022: $15K · 2023: $34K · 2024: $27K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $6,652 · Food and Beverage: $6,283 · Honoraria: $3,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,620.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,603.75 |
| Travel and Lodging | $6,651.80 |
| Food and Beverage | $6,282.73 |
| Honoraria | $3,125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $48,621.25 | 2020-2025 | Pylarify |
| Boston Scientific Corporation | $26,362.07 | 2019-2025 | Spaceoar System, Ams 700, Lithovue |
| Janssen Scientific Affairs, LLC | $13,776.63 | 2022-2024 | Erleada |
| Blue Earth Diagnostics | $6,960.48 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $5,941.85 | 2024 | Biograph Horizon-3r |
| Applied Medical Resources Corporation | $5,746.02 | 2019-2024 | Gelpoint Advanced Access Platform |
| Intuitive Surgical, INC. | $4,975.85 | 2019-2020 | |
| Foundation Medicine, INC. | $4,032.60 | 2019 | |
| Janssen Global Services, LLC | $3,282.50 | 2021 | |
| Myovant Sciences INC. | $3,195.06 | 2021 | |
| Amgen INC. | $2,053.53 | 2019-2022 | |
| Urogen Pharma, INC. | $1,804.21 | 2020-2024 | Jelmyto |
| Edap Technomed INC | $1,772.00 | 2024 | |
| Procept Biorobotics Corporation | $1,584.47 | 2022-2025 | Aquabeam System |
| Teleflex LLC | $1,333.47 | 2022-2023 | Urolift |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Provepharm INC. | $1,142.07 | 2023 | Bludigo |
| C. R. Bard, INC. & Subsidiaries | $988.05 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $969.10 | 2021-2024 | Prolaris |
| Novo Nordisk INC | $595.00 | 2023 | |
| Janssen Biotech, INC. | $591.22 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $392.88 | 2019-2024 | Xtandi, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $260.22 | 2025 | |
| Pfizer INC. | $236.82 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $182.83 | 2019-2025 | Provenge |
| Genzyme Corporation | $144.00 | 2023 | |
| Antares Pharma, INC. | $141.23 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Palette Life Sciences, INC. | $130.69 | 2021-2023 | |
| Tolmar Pharmaceuticals, INC. | $126.92 | 2019-2022 | |
| Accord Healthcare, INC. | $123.62 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.97 | 2019 | |
| Merck Sharp & Dohme LLC | $103.11 | 2022-2024 | Keytruda, Lynparza |
| Abbvie INC. | $95.83 | 2019-2025 | Botox |
| Endo Pharmaceuticals INC. | $82.61 | 2021-2024 | Edex, Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $81.63 | 2023 | Gemtesa, Orgovyx |
| Bioprotect Medical, INC. | $72.71 | 2024-2025 | Bioprotect Balloon Implant System |
| Olympus America INC. | $72.26 | 2023-2024 | Itind System |
| Coloplast Corp | $65.73 | 2023-2024 | Porges Coloplast, Coloplast Tfl Drive |
| Neotract INC. | $60.45 | 2020 | |
| Immunitybio, INC. | $55.30 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $49.87 | 2023 | Lynparza |
| Vertex Pharmaceuticals Incorporated | $42.26 | 2025 | |
| Ethicon US, LLC | $39.94 | 2020 | |
| Urovant Sciences INC | $37.62 | 2022 | |
| Endo USA, INC. | $35.52 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $34.63 | 2024-2025 | Adstiladrin |
| Halozyme INC | $33.26 | 2023 | |
| Alnylam Pharmaceuticals INC. | $31.95 | 2025 | Givlaari |
| Laborie Medical Technologies Corp. | $29.62 | 2021 | |
| Travere Therapeutics, INC. | $25.81 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $24.16 | 2021 | |
| Agiliti Surgical, INC. | $22.51 | 2023 | Sonablate |
| Medtronic, INC. | $19.84 | 2025 | Altaviva |
| 180 Medical, INC. | $17.95 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.97 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,567,526.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Albala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.